Life Sciences: Investment Strategy

Investment Strategy

CRA helps clients quantify unmet market needs, evaluate the potential and risks of new markets and therapies, understand the competitive landscape, and develop short- and long-term forecasts to assess the attractiveness and the size of investments.

Strategic support

  • Support commercial due diligence for both sell or buy side
  • For buyers:
    • Understand product and market
    • Identify red flags
    • Identify synergies and upside potential
  • For sellers:
    • Prepare Information Memorandum
    • Set realistic price expectation and prepare forecast
    • Identify and help fill gaps
    • Identify and help prioritize partners
  • Identify therapy areas of potential interest and level of investment required
  • Evaluate groups of assets
    to acquire, divest
  • Evaluate decisions affecting the business model:
    • How to integrate an acquisition
    • How much to invest in order to establish a sales structure
    • Determine business direction
  • Evaluate new technologies
    to invest in
  • Analyze the potential divestiture of an area

Sample engagements

Clinical development "go / no go" decision
Immuno-oncology opportunity prioritization
Identifying positioning options and optimizing Phase III program
Investment opportunity assessment for a new product
Corporate growth strategy

Our life sciences practice is made up of 185 consultants that blend decades of global business experience with an extensive understanding of life sciences.

Meet our senior team >